179 related articles for article (PubMed ID: 35779872)
1. An overview of chemotoxicity and radiation toxicity in cancer therapy.
Yazbeck V; Alesi E; Myers J; Hackney MH; Cuttino L; Gewirtz DA
Adv Cancer Res; 2022; 155():1-27. PubMed ID: 35779872
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced toxicity in patients with testicular germ cell tumors: The impact of physical fitness and regular exercise.
Amiri A; Chovanec M; Oliva V; Sedliak M; Mego M; Ukropec J; Ukropcová B
Andrology; 2021 Nov; 9(6):1879-1892. PubMed ID: 34245663
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of advanced testicular cancer.
Feldman DR; Bosl GJ; Sheinfeld J; Motzer RJ
JAMA; 2008 Feb; 299(6):672-84. PubMed ID: 18270356
[TBL] [Abstract][Full Text] [Related]
4. [Late toxicity after chemotherapy of malignant testicular tumors].
Jakob A; Kollmannsberger C; Kanz L; Bokemeyer C
Urologe A; 1998 Nov; 37(6):635-47. PubMed ID: 9887493
[TBL] [Abstract][Full Text] [Related]
5. Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients.
Suarez-Ibarrola R; Abufaraj M; Shariat SF
Curr Opin Urol; 2018 Sep; 28(5):485-490. PubMed ID: 30044319
[TBL] [Abstract][Full Text] [Related]
6. Late toxicity following curative treatment of testicular cancer.
Kollmannsberger C; Kuzcyk M; Mayer F; Hartmann JT; Kanz L; Bokemeyer C
Semin Surg Oncol; 1999 Dec; 17(4):275-81. PubMed ID: 10588857
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of relapsed metastatic testicular cancer.
Kollmannsberger C; Honecker F; Bokemeyer C
Expert Opin Pharmacother; 2008 Sep; 9(13):2259-72. PubMed ID: 18710351
[TBL] [Abstract][Full Text] [Related]
8. High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy.
Hapakova N; Sestakova Z; Holickova A; Hurbanova L; Miskovska V; Chovanec M; Rejlekova K; Svetlovska D; Kalavska K; Obertova J; Palacka P; Sycova-Mila Z; Mardiak J; Chovanec M; Mego M
Clin Genitourin Cancer; 2019 Oct; 17(5):e1020-e1025. PubMed ID: 31281064
[TBL] [Abstract][Full Text] [Related]
9. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
10. Long-term complications of chemotherapy for germ cell tumours.
Chaudhary UB; Haldas JR
Drugs; 2003; 63(15):1565-77. PubMed ID: 12887263
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.
Oing C; Seidel C; von Amsberg G; Oechsle K; Bokemeyer C
Expert Opin Pharmacother; 2016; 17(4):545-60. PubMed ID: 26630452
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy of malignant testicular tumors].
Weissbach L; Jaeger N; Hartlapp JH; Boedefeld EA; Vahlensieck W
Urologe A; 1983 Sep; 22 Suppl():310-21. PubMed ID: 6314621
[TBL] [Abstract][Full Text] [Related]
13. Emerging Therapeutic Targets for Male Germ Cell Tumors.
Fankhauser CD; Honecker F; Beyer J; Bode PK
Curr Oncol Rep; 2015 Dec; 17(12):54. PubMed ID: 26449842
[TBL] [Abstract][Full Text] [Related]
14. Management of patients with low-stage nonseminomatous germ cell testicular cancer.
Stephenson AJ; Sheinfeld J
Curr Treat Options Oncol; 2005 Sep; 6(5):367-77. PubMed ID: 16107240
[TBL] [Abstract][Full Text] [Related]
15. Current concepts in clinical therapeutics: testicular cancer.
Bergmann KA
Clin Pharm; 1987 Sep; 6(9):693-706. PubMed ID: 2445518
[TBL] [Abstract][Full Text] [Related]
16. Review of late complications of treatment and late relapse in testicular cancer.
Efstathiou E; Logothetis CJ
J Natl Compr Canc Netw; 2006 Nov; 4(10):1059-70. PubMed ID: 17112453
[TBL] [Abstract][Full Text] [Related]
17. Hairy pinnae after orchiectomy and chemotherapy for testicular cancer: acquired localized hypertrichosis of the ears.
Sänger CF; Dietrich N; Pelivani N; Borradori L; de Viragh PA
Dermatology; 2011; 222(4):289-91. PubMed ID: 21464562
[TBL] [Abstract][Full Text] [Related]
18. Delivering Chemotherapy to a Metastatic Poor Risk Testicular Cancer Patient on Hemodialysis.
Moore KJ; Snow S; Wood LA
Curr Oncol; 2022 Mar; 29(3):1808-1812. PubMed ID: 35323348
[TBL] [Abstract][Full Text] [Related]
19. Status of chemotherapy for testis cancer.
Loehrer PJ; Williams SD; Einhorn LH
Urol Clin North Am; 1987 Nov; 14(4):713-20. PubMed ID: 2823440
[TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular accident during cisplatin-based combination chemotherapy of testicular germ cell tumor: an unusual case report.
Azak A; Oksüzoğlu B; Deren T; Oneç BM; Zengin N
Anticancer Drugs; 2008 Jan; 19(1):97-8. PubMed ID: 18043135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
